Phase 2, open-label, activity, pharmacodynamic, pharmacokinetic, and safety study of PTC299 in patients with neurofibromatosis type 2
Ended Project Grant Awarded Last action
- Award ID
- W81XWH0910182
- Recipient
-
PTC Therapeutics, Inc. UEI LH7QEHP9V7W1
- Awarding agency
-
Department of Defense
- Obligated
- $296,888
Award facts
- Assistance listing
- 12.420 Military Medical Research and Development
- Completion date
- Place of performance
- South Plainfield, NJ 07080, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | -$525,457 | |
| Original award | $822,345 |
Quick answers
Who received award W81XWH0910182?
W81XWH0910182 was awarded to PTC Therapeutics, Inc. by Department of Defense on May 1, 2009.
How much is award W81XWH0910182 worth?
$296,888 has been obligated on W81XWH0910182.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award